A Multifaceted Approach to the Prevention of Clostridioides (Clostridium) Difficile

被引:2
|
作者
Pate, Kimberly [1 ]
Reece, Jennifer [2 ]
Smyre, Alex [3 ]
机构
[1] Carolinas Med Ctr, Surg Trauma Div, Charlotte, NC 28203 USA
[2] Carolinas Med Ctr, Charlotte, NC 28203 USA
[3] Carolinas Med Ctr, Infect Prevent, Charlotte, NC 28203 USA
关键词
clinical nurse specialist; Clostridium difficile; diarrhea; documentation; electronic medical record; quality improvement; INFECTION; VALIDATION; BUNDLE; IMPACT;
D O I
10.1097/NUR.0000000000000426
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Purpose/Objectives The purpose of this project was to design and implement a sustainable program to reduce hospital-acquired cases of Clostridioides difficile. Description of the Project Experiencing higher rates in a large, academic medical center, hospital leaders were assembled. The overall facility rate was 6.9% in 2014 with a first quarter rate of 8.4% in 2015. Individual unit rates were as high as 19.8%. A team of key stakeholders was assembled to plan, execute, and reevaluate targeted solutions. Strategies implemented were an innovative, automated screening tool, an evidence-based prevention bundle; and staff education. Outcomes A facility-wide C difficile prevention program was implemented with a sustained decrease in rates observed from 8.4% in the first quarter of 2015 to 6.0% in the fourth quarter of 2017. The standardized infection ratio ranged from 0.541 to 0.889, consistently below the national mean. Conclusion Clostridioides difficile is a leading cause of hospital-associated diarrhea and a tremendous burden on healthcare systems increasing morbidity, mortality, and financial strain. A multidisciplinary, multifaceted approach was critical to ensure early detection, reduce risk of transmission, and decrease overall rates.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [41] Prevention and treatment of Clostridium difficile infection
    Gouliouris, Theodore
    Brown, Nicholas M.
    Aliyu, Sani H.
    CLINICAL MEDICINE, 2011, 11 (01) : 75 - 79
  • [42] Bezlotoxumab for the prevention of Clostridium difficile recurrence
    Couture-Cossette, Antoine
    Carignan, Alex
    Ilangumaran, Subburaj
    Valiquette, Louis
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (11) : 1439 - 1445
  • [43] Strategies for prevention of Clostridium difficile infection
    Dubberke, Erik
    JOURNAL OF HOSPITAL MEDICINE, 2012, 7 : S14 - S17
  • [44] Prevention of Clostridium difficile Infection With Probiotics
    Evans, Charlesnika T.
    Johnson, Stuart
    CLINICAL INFECTIOUS DISEASES, 2015, 60 : S122 - S128
  • [45] Colonization for the prevention of Clostridium difficile disease
    Gerding, DN
    ANAEROBE, 1999, 5 (3-4) : 195 - 199
  • [46] Clostridium difficile Colitis Prevention and Treatment
    Dinleyici, Meltem
    Vandenplas, Yvan
    PROBIOTICS AND CHILD GASTROINTESTINAL HEALTH: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 10, 2019, 1125 : 139 - 146
  • [47] Clostridium difficile Infection: Prevention and Treatment
    Barreto, Tyler W.
    Lin, Kenneth W.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (03) : 196 - 199
  • [48] Emerging Options for the Prevention and Management of Clostridioides difficile Infection
    Gonzales-Luna, Anne J. J.
    Carlson, Travis J. J.
    Garey, Kevin W. W.
    DRUGS, 2023, 83 (02) : 105 - 116
  • [49] How to: prophylactic interventions for prevention of Clostridioides difficile infection
    Reigadas, Elena
    van Prehn, Joffrey
    Falcone, Marco
    Fitzpatrick, Fidelma
    Vehreschild, Maria J. G. T.
    Kuijper, Ed J.
    Bouza, Emilio
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1777 - 1783
  • [50] Recurrent Clostridioides difficile infection: Recognition, management, prevention
    Tsigrelis, Constantine
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (06) : 347 - 359